Trial Profile
Clinical Trials Insight: 700027463
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 18 Jun 2009
Price :
$35
*
At a glance
- Drugs TG 4040 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- Sponsors Transgene
- 10 Oct 2007 Status change
- 08 Oct 2007 New trial record.